Elkon; Keith
Patent Applications and Registrations
Patent applications and USPTO patent grants for Elkon; Keith.The latest application filed is for "therapeutic nuclease compositions and methods".
- Elkon; Keith - Seattle WA
- Elkon; Keith - Larchmont NY
- Elkon; Keith - New York NY
| Patent | Date |
|---|---|
| Therapeutic nuclease compositions and methods Grant 11,306,297 - Ledbetter , et al. April 19, 2 | 2022-04-19 |
| Therapeutic Nuclease Compositions and Methods App 20210395711 - Ledbetter; Jeffrey A. ; et al. | 2021-12-23 |
| Compositions And Methods For Treating Inflammatory Diseases App 20210215692 - Lood; Jan Christian ; et al. | 2021-07-15 |
| Therapeutic nuclease compositions and methods Grant 11,034,944 - Ledbetter , et al. June 15, 2 | 2021-06-15 |
| CGAS in systemic lupus erythematosus (SLE) Grant 10,329,258 - Elkon , et al. | 2019-06-25 |
| Therapeutic Nuclease Compositions and Methods App 20190119660 - Ledbetter; Jeffrey A. ; et al. | 2019-04-25 |
| Therapeutic nuclease compositions and methods Grant 10,202,588 - Ledbetter , et al. Feb | 2019-02-12 |
| Therapeutic Nuclease Compositions and Methods App 20180187174 - Ledbetter; Jeffrey A. ; et al. | 2018-07-05 |
| Therapeutic nuclease compositions and methods Grant 10,000,745 - Ledbetter , et al. June 19, 2 | 2018-06-19 |
| Cgas In Systemic Lupus Erythematosus (sle) App 20180086713 - ELKON; Keith ; et al. | 2018-03-29 |
| Therapeutic nuclease compositions and methods Grant 9,790,479 - Ledbetter , et al. October 17, 2 | 2017-10-17 |
| Therapeutic Nuclease Compositions and Methods App 20150152399 - Ledbetter; Jeffrey A. ; et al. | 2015-06-04 |
| Therapeutic Nuclease Compositions And Methods App 20150037871 - Ledbetter; Jeffrey A. ; et al. | 2015-02-05 |
| Therapeutic nuclease compositions and methods Grant 8,937,157 - Ledbetter , et al. January 20, 2 | 2015-01-20 |
| Therapeutic nuclease compositions and methods Grant 8,841,416 - Ledbetter , et al. September 23, 2 | 2014-09-23 |
| Therapeutic Nuclease Compositions And Methods App 20140227269 - Ledbetter; Jeffrey A. ; et al. | 2014-08-14 |
| Therapeutic Nuclease Compositions and Methods App 20140178379 - Ledbetter; Jeffrey A. ; et al. | 2014-06-26 |
| Therapeutic Nuclease Compositions and Methods App 20140044711 - Ledbetter; Jeffrey A. ; et al. | 2014-02-13 |
| Antibody composition with altered Fab sialylation Grant 8,632,773 - Kasermann , et al. January 21, 2 | 2014-01-21 |
| Therapeutic Nuclease Compositions And Methods App 20130183308 - Ledbetter; Jeffrey A. ; et al. | 2013-07-18 |
| Therapeutic Nuclease Compositions And Methods App 20130184334 - Ledbetter; Jeffrey A. ; et al. | 2013-07-18 |
| Therapeutic Nuclease Compositions And Methods App 20130177561 - Ledbetter; Jeffrey A. ; et al. | 2013-07-11 |
| Therapeutic Nuclease Compositions And Methods App 20130089546 - Ledbetter; Jeffrey A. ; et al. | 2013-04-11 |
| Therapeutic Nuclease Compositions And Methods App 20120225066 - Ledbetter; Jeffrey A. ; et al. | 2012-09-06 |
| Antibody Composition With Altered Fab Sialylation App 20120009189 - Kasermann; Fabian ; et al. | 2012-01-12 |
| Method of inhibiting and immune response to a recombinant vector Grant 6,525,029 - Falck-Pedersen , et al. February 25, 2 | 2003-02-25 |
| Method of detecting ribosomal protein antibodies in systemic lupus erythematosus Grant 4,865,970 - Brot , et al. September 12, 1 | 1989-09-12 |
| NCAGE Code | 4NP27 | ELKON KEITH |
| CAGE Code | 4NP27 | ELKON, KEITH |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 